BioCardia announces data verification completion for Phase 3 CardiAMP HF study on heart failure treatment, with results due March 30, 2025. BioCardia, Inc. has completed source data verification ...

TRI, a leading innovator in Risk-Based Quality Management (RBQM) technology, today announced the launch of the latest version of OPRA-CM, a reimagined centralized monitoring platform built to help ...

That said, DePIN data verification matters even if data isn ... private keys to sign all the data they broadcast at the source is a good device-agnostic first step that allows us to track ...

CIOs should prioritize implementing robust source verification mechanisms to ensure the reliability and accuracy of the data the AI chatbots provide. By doing so, they can mitigate the risks ...

today announced the completion of source data verification and freezing of primary outcomes data in the double-blind randomized placebo-controlled Phase 3 CardiAMP HF study of its autologous ...